Corrigendum re "Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma" [Eur Urol 2017;72:747-54]

Mitchell J Machiela¹, Jonathan N Hofmann¹, Robert Carreras-Torres², Kevin M Brown¹, Mattias Johansson², Zhaoming Wang³, Matthieu Foll², Peng Li², Nathaniel Rothman¹, Sharon A Savage¹, Valerie Gaborieau², James D McKay², Yuanqing Ye⁴, Marc Henrion⁵, Fiona Bruinsma⁶, Susan Jordan⁷, Gianluca Severi⁸, Kristian Hveem⁹, Lars J Vatten¹⁰, Tony Fletcher¹¹, Kvetoslava Koppova¹², Susanna C Larsson¹³, Alicja Wolk¹³, Rosamonde E Banks¹⁴, Peter J Selby¹⁴, Douglas F Easton¹⁵, Paul Pharoah¹⁵, Gabriella Andreotti¹, Laura E Beane Freeman¹, Stella Koutros¹, Demetrius Albanes¹, Satu Mannisto¹⁶, Stephanie Weinstein¹, Peter E Clark¹⁷, Todd E Edwards¹⁷, Loren Lipworth¹⁷, Susan M Gapstur¹⁸, Victoria L Stevens¹⁸, Hallie Carol¹⁹, Matthew L Freedman¹⁹, Mark M Pomerantz¹⁹, Eunyoung Cho²⁰, Peter Kraft²¹, Mark A Preston²², Kathryn M Wilson²¹, J Michael Gaziano²³, Howard S Sesso²¹, Amanda Black¹, Neal D Freedman¹, Wen-Yi Huang¹, John G Anema²⁴, Richard J Kahnoski²⁴, Brian R Lane²⁵, Sabrina L Noyes²⁶, David Petillo²⁶, Leandro M Colli¹, Joshua N Sampson¹, Celine Besse²⁷, Helene Blanche²⁸, Anne Boland²⁷, Laurie Burdette¹, Egor Prokhortchouk²⁹, Konstantin G Skryabin²⁹, Meredith Yeager¹, Mirjana Mijuskovic³⁰, Miodrag Ognjanovic³¹, Lenka Foretova³², Ivana Holcatova³³, Vladimir Janout³⁴, Dana Mates³⁵, Anush Mukeriya³⁶, Stefan Rascu³⁷, David Zaridze³⁶, Vladimir Bencko³⁸, Cezary Cybulski³⁹, Eleonora Fabianova¹², Viorel Jinga³⁷, Jolanta Lissowska⁴⁰, Jan Lubinski³⁹, Marie Navratilova³², Peter Rudnai⁴¹, Neonila Szeszenia-Dabrowska⁴², Simone Benhamou⁴³, Geraldine Cancel-Tassin⁴⁴, Olivier Cussenot⁴⁵, H B As Bueno-de-Mesquita⁴⁶, Federico Canzian⁴⁷, Eric J Duell⁴⁸, Börje Ljungberg⁴⁹, Raviprakash T Sitaram⁴⁹, Ulrike Peters⁵⁰, Emily White⁵⁰, Garnet L Anderson⁵⁰, Lisa Johnson⁵⁰, Juhua Luo⁵¹, Julie Buring²¹, I-Min Lee⁵², Wong-Ho Chow⁴, Lee E Moore¹, Christopher Wood⁵³, Timothy Eisen⁵⁴, James Larkin⁵⁵, Toni K Choueiri¹⁹, G Mark Lathrop⁵⁶, Bin Tean Teh²⁶, Jean-Francois Deleuze⁵⁷, Xifeng Wu⁴, Richard S Houlston⁵⁸, Paul Brennan², Stephen J Chanock¹, Ghislaine Scelo², Mark P Purdue⁵⁹

Affiliations

¹ Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.
² International Agency for Research on Cancer (IARC), Lyon, France.
³ St. Jude Children's Research Hospital, Memphis, TN, USA.
⁴ Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁵ Icahn School of Medicine, New York, NY, USA.
⁶ Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Australia.
⁷ QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia; School of Public Health, The University of Queensland, Brisbane, Australia.
⁸ Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Carlton, Australia; Human Genetics Foundation (HuGeF), Torino, Italy; Centre de Recherche en Épidémiologie et Santé des Populations, Université Paris-Saclay, UPS, USQ, Gustave Roussy, Villejuif, France.
⁹ HUNT Research Centre, Department of Public Health and General Practice, Norwegian University of Science and Technology, Levanger, Sweden.
¹⁰ Department of Public Health and General Practice, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
¹¹ London School of Hygiene and Tropical Medicine, University of London, London, UK.
¹² Regional Authority of Public Health in Banska Bystrica, Banska Bystrica, Slovakia.
¹³ Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
¹⁴ Leeds Institute of Cancer and Pathology, University of Leeds, Cancer Research Building, St James's University Hospital, Leeds, UK.
¹⁵ Department of Oncology, and Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
¹⁶ National Institute for Health and Welfare, Helsinki, Finland.
¹⁷ Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
¹⁸ American Cancer Society, Atlanta, GA, USA.
¹⁹ Dana-Farber Cancer Institute, Boston, MA, USA.
²⁰ Brown University, Providence, RI, USA.
²¹ Harvard T.H. Chan School of Public Health, Boston, MA, USA.
²² Brigham and Women's Hospital, Boston, MA, USA.
²³ Brigham and Women's Hospital, Boston, MA, USA; Veterans Administration, Boston, MA, USA.
²⁴ Division of Urology, Spectrum Health, Grand Rapids, MI, USA.
²⁵ Division of Urology, Spectrum Health, Grand Rapids, MI, USA; College of Human Medicine, Michigan State University, Grand Rapids, MI, USA.
²⁶ Van Andel Research Institute, Center for Cancer Genomics and Quantitative Biology, Grand Rapids, MI, USA.
²⁷ Centre National de Recherche en Genomique Humaine (CNRGH), Institut de biologie François Jacob, Commissariat à l'Energie Atomique et aux Energies Alternatives, Evry, France.
²⁸ Fondation Jean Dausset-Centre d'Etude du Polymorphisme Humain, Paris, France.
²⁹ Center 'Bioengineering' of the Russian Academy of Sciences, Moscow, Russian Federation; Kurchatov Scientific Center, Moscow, Russian Federation.
³⁰ Clinic for Nephrology, Military Medical Academy, Belgrade, Serbia.
³¹ International Organization for Cancer Prevention and Research (IOCPR), Belgrade, Serbia.
³² Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
³³ Second Faculty of Medicine, Institute of Public Health and Preventive Medicine, Charles University, Prague, Czech Republic.
³⁴ Department of Preventive Medicine, Faculty of Medicine, Palacky University, Czech Republic.
³⁵ National Institute of Public Health, Bucharest, Romania.
³⁶ Russian N.N. Blokhin Cancer Research Centre, Moscow, Russian Federation.
³⁷ Carol Davila University of Medicine and Pharmacy, Th. Burghele Hospital, Bucharest, Romania.
³⁸ First Faculty of Medicine, Institute of Hygiene and Epidemiology, Charles University, Prague, Czech Republic.
³⁹ International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
⁴⁰ The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland.
⁴¹ National Public Health Center, National Directorate of Environmental Health, Budapest, Hungary.
⁴² Department of Epidemiology, Institute of Occupational Medicine, Lodz, Poland.
⁴³ INSERM U946, Paris, France; CNRS UMR8200, Institute Gustave Roussy, Villejuif, France.
⁴⁴ CeRePP, Paris, France; UPMC Univ Paris 06, Institut Universitaire de Cancérologie, Paris, France.
⁴⁵ CeRePP, Paris, France; UPMC Univ Paris 06, Institut Universitaire de Cancérologie, Paris, France; AP-HP, Department of Urology, Hopitaux Universitaires Est Parisien Tenon, Paris, France.
⁴⁶ Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands; Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, London, UK; Department of Social & Preventive Medicine, Faculty of Medicine, University of Malaya, Pantai Valley, Kuala Lumpur, Malaysia.
⁴⁷ Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁴⁸ Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
⁴⁹ Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.
⁵⁰ Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
⁵¹ Department of Epidemiology and Biostatistics, School of Public Health Indiana University Bloomington, Bloomington, IN, USA.
⁵² Harvard T.H. Chan School of Public Health, Boston, MA, USA; Brigham and Women's Hospital, Boston, MA, USA.
⁵³ Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁵⁴ University of Cambridge, Cambridge, UK.
⁵⁵ Royal Marsden NHS Foundation Trust, London, UK.
⁵⁶ McGill University and Genome Quebec Innovation Centre, Montreal, QC, Canada.
⁵⁷ Centre National de Recherche en Genomique Humaine (CNRGH), Institut de biologie François Jacob, Commissariat à l'Energie Atomique et aux Energies Alternatives, Evry, France; Fondation Jean Dausset-Centre d'Etude du Polymorphisme Humain, Paris, France.
⁵⁸ The Institute of Cancer Research, London, UK.
⁵⁹ Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA. Electronic address: purduem@mail.nih.gov.

PMID: 29853305
PMCID: PMC7400767
DOI: 10.1016/j.eururo.2018.05.017

Published Erratum

Corrigendum re "Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma" [Eur Urol 2017;72:747-54]

Mitchell J Machiela et al. Eur Urol. 2018 Sep.

. 2018 Sep;74(3):e85-e86.

doi: 10.1016/j.eururo.2018.05.017. Epub 2018 May 28.

Authors

Affiliations

¹ Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.
² International Agency for Research on Cancer (IARC), Lyon, France.
³ St. Jude Children's Research Hospital, Memphis, TN, USA.
⁴ Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁵ Icahn School of Medicine, New York, NY, USA.
⁶ Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Australia.
⁷ QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia; School of Public Health, The University of Queensland, Brisbane, Australia.
⁸ Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Carlton, Australia; Human Genetics Foundation (HuGeF), Torino, Italy; Centre de Recherche en Épidémiologie et Santé des Populations, Université Paris-Saclay, UPS, USQ, Gustave Roussy, Villejuif, France.
⁹ HUNT Research Centre, Department of Public Health and General Practice, Norwegian University of Science and Technology, Levanger, Sweden.
¹⁰ Department of Public Health and General Practice, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
¹¹ London School of Hygiene and Tropical Medicine, University of London, London, UK.
¹² Regional Authority of Public Health in Banska Bystrica, Banska Bystrica, Slovakia.
¹³ Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
¹⁴ Leeds Institute of Cancer and Pathology, University of Leeds, Cancer Research Building, St James's University Hospital, Leeds, UK.
¹⁵ Department of Oncology, and Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
¹⁶ National Institute for Health and Welfare, Helsinki, Finland.
¹⁷ Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
¹⁸ American Cancer Society, Atlanta, GA, USA.
¹⁹ Dana-Farber Cancer Institute, Boston, MA, USA.
²⁰ Brown University, Providence, RI, USA.
²¹ Harvard T.H. Chan School of Public Health, Boston, MA, USA.
²² Brigham and Women's Hospital, Boston, MA, USA.
²³ Brigham and Women's Hospital, Boston, MA, USA; Veterans Administration, Boston, MA, USA.
²⁴ Division of Urology, Spectrum Health, Grand Rapids, MI, USA.
²⁵ Division of Urology, Spectrum Health, Grand Rapids, MI, USA; College of Human Medicine, Michigan State University, Grand Rapids, MI, USA.
²⁶ Van Andel Research Institute, Center for Cancer Genomics and Quantitative Biology, Grand Rapids, MI, USA.
²⁷ Centre National de Recherche en Genomique Humaine (CNRGH), Institut de biologie François Jacob, Commissariat à l'Energie Atomique et aux Energies Alternatives, Evry, France.
²⁸ Fondation Jean Dausset-Centre d'Etude du Polymorphisme Humain, Paris, France.
²⁹ Center 'Bioengineering' of the Russian Academy of Sciences, Moscow, Russian Federation; Kurchatov Scientific Center, Moscow, Russian Federation.
³⁰ Clinic for Nephrology, Military Medical Academy, Belgrade, Serbia.
³¹ International Organization for Cancer Prevention and Research (IOCPR), Belgrade, Serbia.
³² Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
³³ Second Faculty of Medicine, Institute of Public Health and Preventive Medicine, Charles University, Prague, Czech Republic.
³⁴ Department of Preventive Medicine, Faculty of Medicine, Palacky University, Czech Republic.
³⁵ National Institute of Public Health, Bucharest, Romania.
³⁶ Russian N.N. Blokhin Cancer Research Centre, Moscow, Russian Federation.
³⁷ Carol Davila University of Medicine and Pharmacy, Th. Burghele Hospital, Bucharest, Romania.
³⁸ First Faculty of Medicine, Institute of Hygiene and Epidemiology, Charles University, Prague, Czech Republic.
³⁹ International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
⁴⁰ The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland.
⁴¹ National Public Health Center, National Directorate of Environmental Health, Budapest, Hungary.
⁴² Department of Epidemiology, Institute of Occupational Medicine, Lodz, Poland.
⁴³ INSERM U946, Paris, France; CNRS UMR8200, Institute Gustave Roussy, Villejuif, France.
⁴⁴ CeRePP, Paris, France; UPMC Univ Paris 06, Institut Universitaire de Cancérologie, Paris, France.
⁴⁵ CeRePP, Paris, France; UPMC Univ Paris 06, Institut Universitaire de Cancérologie, Paris, France; AP-HP, Department of Urology, Hopitaux Universitaires Est Parisien Tenon, Paris, France.
⁴⁶ Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands; Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, London, UK; Department of Social & Preventive Medicine, Faculty of Medicine, University of Malaya, Pantai Valley, Kuala Lumpur, Malaysia.
⁴⁷ Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁴⁸ Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
⁴⁹ Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.
⁵⁰ Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
⁵¹ Department of Epidemiology and Biostatistics, School of Public Health Indiana University Bloomington, Bloomington, IN, USA.
⁵² Harvard T.H. Chan School of Public Health, Boston, MA, USA; Brigham and Women's Hospital, Boston, MA, USA.
⁵³ Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁵⁴ University of Cambridge, Cambridge, UK.
⁵⁵ Royal Marsden NHS Foundation Trust, London, UK.
⁵⁶ McGill University and Genome Quebec Innovation Centre, Montreal, QC, Canada.
⁵⁷ Centre National de Recherche en Genomique Humaine (CNRGH), Institut de biologie François Jacob, Commissariat à l'Energie Atomique et aux Energies Alternatives, Evry, France; Fondation Jean Dausset-Centre d'Etude du Polymorphisme Humain, Paris, France.
⁵⁸ The Institute of Cancer Research, London, UK.
⁵⁹ Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA. Electronic address: purduem@mail.nih.gov.

PMID: 29853305
PMCID: PMC7400767
DOI: 10.1016/j.eururo.2018.05.017

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: The authors have nothing to disclose.

Erratum for

Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.
Machiela MJ, Hofmann JN, Carreras-Torres R, Brown KM, Johansson M, Wang Z, Foll M, Li P, Rothman N, Savage SA, Gaborieau V, McKay JD, Ye Y, Henrion M, Bruinsma F, Jordan S, Severi G, Hveem K, Vatten LJ, Fletcher T, Koppova K, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Pharoah P, Andreotti G, Freeman LEB, Koutros S, Albanes D, Mannisto S, Weinstein S, Clark PE, Edwards TE, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Kraft P, Preston MA, Wilson KM, Gaziano JM, Sesso HS, Black A, Freedman ND, Huang WY, Anema JG, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Colli LM, Sampson JN, Besse C, Blanche H, Boland A, Burdette L, Prokhortchouk E, Skryabin KG, Yeager M, Mijuskovic M, Ognjanovic M, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Szeszenia-Dabrowska N, Benhamou S, Cancel-Tassin G, Cussenot O, Bueno-de-Mesquita HB, Canzian F, Duell EJ, Ljungberg B, Sitaram RT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, Chow WH, Moore LE, Wood C, Eisen T, Larkin J, Choueiri TK, Lathrop GM, Teh BT, Deleuze JF, Wu X,… See abstract for full author list ➔ Machiela MJ, et al. Eur Urol. 2017 Nov;72(5):747-754. doi: 10.1016/j.eururo.2017.07.015. Epub 2017 Aug 7. Eur Urol. 2017. PMID: 28797570 Free PMC article.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Corrigendum re "Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma" [Eur Urol 2017;72:747-54]

Affiliations

Corrigendum re "Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma" [Eur Urol 2017;72:747-54]

Authors

Affiliations

Conflict of interest statement

Erratum for

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources